UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 Or 15(D) of The
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): June 27, 2003
ANTARES PHARMA, INC.
--------------------
(Exact Name of Registrant as Specified in Charter)
Minnesota 0-20945 41-1350192
--------- ------- ----------
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
707 Eagleview Boulevard, Suite 414, Exton, PA 19341
----------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (610) 458-6200
Not Applicable
-------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events and Required FD Disclosure.
On June 30, 2003, Antares Pharma, Inc. (the "Company") announced that on June 27
2003, the Listing Qualifications arm of The Nasdaq Stock Market, Inc. had
determined to delist the Company's shares of common stock from trading on The
Nasdaq SmallCap Market effective with the open of business on Tuesday, July 1,
2003. The Company's common stock will be immediately eligible for quotation on
the OTC Bulletin Board effective with the open of business on Tuesday, July 1,
2003, provided that a market maker enters a quote for such securities on the
first day of eligibility. The Company's common stock will trade under the same
ticker symbol: ANTR.
A copy of the press release issued by the Company on June 30, 2003 is
attached hereto as Exhibit 99.1
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
99.1 Press Release dated June 30, 2003.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: June 30, 2003 ANTARES PHARMA, INC.
By /s/ Lawrence M. Christian
---------------------------
Lawrence M. Christian
Chief Financial Officer
EXHIBIT INDEX
99.1 Press Release dated June 30, 2003.